In vitro, we silenced the expression of NDC1 in human pancreatic cancer cell lines BxPC-3 and MIA PaCa-2, respectively, and the interference efficiency was verified by RT-qPCR and Western blot analysis (Figure 11A, 11B). The gene discussed is NDC1; the disease is familial pancreatic carcinoma.